Managing Liver Issues in HIV Patients
Author Information
Author(s): Esposito Antonella, Conti Valentina, Cagliuso Maria, Pastori Daniele, Fantauzzi Alessandra, Mezzaroma Ivano
Primary Institution: Department of Clinical Medicine, 'Sapienza'- University of Rome, Rome, Italy
Hypothesis
Can effective antiretroviral therapy (HAART) control liver enzyme elevations in HIV-1 infected patients?
Conclusion
The study found that liver enzyme levels returned to normal after effective HAART was initiated in HIV-1 infected patients with elevated liver enzymes.
Supporting Evidence
- All patients had severe immunodeficiency with CD4+ T cells less than 200/cu.mm.
- Liver enzyme levels normalized after starting effective HAART.
- No other causes of liver injury were identified in the patients.
Takeaway
When people with HIV have high liver enzyme levels, giving them the right medicine can help their liver feel better again.
Methodology
The study reported three case studies of HIV-1 infected patients with elevated liver enzymes and assessed their response to HAART.
Limitations
The study is based on only three case reports, limiting the generalizability of the findings.
Participant Demographics
All three patients were HIV-1 positive men with advanced immunodeficiency.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website